Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Cancer ; 14(16): 3050-3065, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37859819

RESUMO

Background: Bladder cancer (BLCA) is one of the common malignant tumors worldwide. Recent studies have shown that Transcription factor activating protein-2(TFAP2) family proteins plays a bidirectional regulatory role in the process of tumorigenesis versus evolution by regulating the expression of tumor associated genes. However, little is known about the function of distinct TFAP2s proteins in patient with BLCA. Methods: Formalin-fixed paraffin-embedded (FFPE) sample tissues and clinical data of 240 patients with bladder cancer were collected for immunohistochemical analysis. The Human Protein Atlas, Gene Expression Profiling Interactive Analysis (GEPIA), Shiny Methylation Analysis Resource Tool (SMART), Kaplan-Meier plotter, cBioPortal, Metascape, LinkedOmics, TIMER and CIBERSORT were utilized to analyze differential expression, prognostic value, genetic alteration and immune cell infiltration of TFAP2 family in patients with BLCA. Results: Our study found that TFAP2 family proteins are generally expressed higher in BLCA tissues than in normal tissues. However, they show different trends in the growth, metastasis and survival prognosis of BLCA. TFAP2A and TFAP2C was associated with worse clinical stage and prognosis in BLCA patients, while TFAP2B, TFAP2D and TFAP2E showed the opposite trend. Importantly, the functions of the differentially expressed TFAP2s were primarily related to the developmental process, reproductive process, response to stimulus and immune system process, etc. Moreover, TFAP2 family was significantly correlated with the infiltration of six immune cell types and might regulate TAM polarization. Conclusion: TFAP2 family might be an important regulator of immune cell infiltration and a valuable prognostic biomarker in patients with BLCA.

3.
Oncol Lett ; 15(4): 5634-5642, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29556300

RESUMO

The aim of the present study was to investigate the optimal strategy and dosimetric measurement of thoracic radiotherapy based on three-dimensional (3D) modeling of mediastinal lymph nodes (MLNs). A 3D model of MLNs was constructed from a Chinese Visible Human female dataset. Image registration and fusion between reconstructed MLNs and original chest computed tomography (CT) images was conducted in the Eclipse™ treatment planning system (TPS). There were three plans, including 3D conformal radiotherapy (3D-CRT), intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT), which were designed based on 10 cases of simulated lung lesions (SLLs) and MLNs. The quality of these plans was evaluated via examining indexes, including conformity index (CI), homogeneity index and clinical target volume (CTV) coverage. Dose-volume histogram analysis was performed on SLL, MLNs and organs at risk (OARs). A Chengdu Dosimetric Phantom (CDP) was then drilled at specific MLNs according to 20 patients with thoracic tumors and of a medium-build. These plans were repeated on fused MLNs and CDP CT images in the Eclipse™ TPS. Radiation doses at the SLLs and MLNs of the CDP were measured and compared with calculated doses. The established 3D MLN model demonstrated the spatial location of MLNs and adjacent structures. Precise image registration and fusion were conducted between reconstructed MLNs and the original chest CT or CDP CT images. IMRT demonstrated greater values in CI, CTV coverage and OAR (lungs and spinal cord) protection, compared with 3D-CRT and VMAT (P<0.05). The deviation between the measured and calculated doses was within ± 10% at SLL, and at the 2R and 7th MLN stations. In conclusion, the 3D MLN model can benefit plan optimization and dosimetric measurement of thoracic radiotherapy, and when combined with CDP, it may provide a tool for clinical dosimetric monitoring.

4.
Oncol Lett ; 11(5): 3389-3394, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-27123122

RESUMO

The aim of the present study was to investigate volumetric-modulated arc therapy (VMAT) with single arc (1ARC) and dual arc (2ARC), and intensity-modulated radiation therapy (IMRT), and to evaluate the quality and delivery efficiency of post-mastectomy regional irradiation. A total of 24 female patients who required post-mastectomy regional irradiation were enrolled into the current study, and 1ARC, 2ARC and IMRT plans were designed for each individual patient. The quality of these plans was evaluated by calculating the homogeneity index (HI), conformity index (CI) and specific volume dose to the ipsilateral lung, double lungs, contralateral breast, heart and spinal cord. For the delivery efficiency of these plans, the total treatment time (TTT) and the number of monitor units (MUs) were evaluated. The 1ARC and 2ARC VMAT plans exhibited significantly better HIs and CIs than IMRT. For dose-volume histogram analysis, 1ARC and 2ARC VMAT spared a more specific volume dose to the ipsilateral lung, double lungs, contralateral breast, heart and spinal cord than IMRT (P<0.05). A lower MU per 2.0-Gy fraction was required for 1ARC (539 MU) and 2ARC (608 MU) than for IMRT (1,051 MU). Thus, TTT was correspondingly reduced in 1ARC and 2ARC compared to IMRT (P<0.05). There was no significant dose-volume difference in all the organs at risk (OARs) between the 1ARC and 2ARC plans (P>0.05), and 2ARC VMAT displayed a better HI and CI than 1ARC VMAT (P<0.05). By contrast, 1ARC VMAT was superior to 2ARC VAMT with regard to MU and TTT (P<0.05). The 1ARC and 2ARC VMAT plans demonstrated significantly better dose distribution in a shorter treatment time than IMRT for post-mastectomy regional irradiation, and spared the majority of OARs without compromising target coverage. The results of the present study suggest that 2ARC VMAT may be an alternative to 1ARC in order to obtain a more optimal HI and CI.

5.
Phys Med ; 32(1): 266-71, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26703446

RESUMO

The demand for greater accuracy of intensity-modulated radiotherapy (IMRT) has driven the development of more advanced verification systems for image-guided radiotherapy (IGRT). The purpose of this study is to investigate setup discrepancies measured between an orthogonal X-ray guidance system (XGS-10) and cone-beam computed tomography (CBCT) of Varian in the IMRT of patients with nasopharyngeal cancer (NPC). The setup errors measured by XGS-10 and CBCT at the treatment unit with respect to the planning CTs were recorded for 30 patients with NPC. The differences in residual setup errors between XGS-10 system and CBCT were computed and quantitatively analyzed. The time of image acquisition and image registration was recorded. The radiation doses delivered by CBCT and XGS-10 were measured using PTW0.6CC ionization chambers and a water phantom. The differences between setup errors measured by the XGS-10 system and CBCT were generally <1.5 mm for translations, indicating a reasonably good agreement between the two systems for patients with NPC in the translation directions of A-P (P = 0.856), L-R (P = 0.856) and S-I (P = 0.765). Moreover, compared with CBCT, XGS-10 took much shorter image acquisition and registration time (P <0.001) and delivered only a small fraction of extra radiation dose to the patients (P <0.001). These results indicate that XGS-10 offers high localization accuracy similar to CBCT and additional benefits including prompt imaging process, low imaging radiation exposure, real time monitoring, which therefore represents a potential attractive alternative to CBCT for clinical use.


Assuntos
Tomografia Computadorizada de Feixe Cônico/métodos , Neoplasias Nasofaríngeas/radioterapia , Radiografia/métodos , Radioterapia Guiada por Imagem/métodos , Algoritmos , Carcinoma , Simulação por Computador , Desenho de Equipamento , Humanos , Processamento de Imagem Assistida por Computador , Carcinoma Nasofaríngeo , Imagens de Fantasmas , Doses de Radiação , Radiometria , Planejamento da Radioterapia Assistida por Computador/métodos , Radioterapia de Intensidade Modulada , Reprodutibilidade dos Testes , Estudos Retrospectivos , Água , Raios X
6.
Cancer Biother Radiopharm ; 27(2): 119-23, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22149642

RESUMO

OBJECTIVE: To explore the best time to carry out total body irradiation (TBI) in hematopoietic stem cell transplantation (HSCT) pretreatment. METHODS: Retrospective analysis was applied in 88 cases of HSCT using TBI as pretreatment from March 2001 to June 2009 in our hospital. Using 8 MV X-ray, all the patients were irradiated by linear accelerator in 2 consecutive days, with a total dose of 7-11 Gy and an instantaneous dose rate ranging between 4.0 and 5.0 cGy/min. Of the 88 cases, 40 cases were given traditional high-dose chemotherapy before TBI (Group CT/TBI), and 48 cases were given TBI before chemotherapy (Group TBI/CT) instead. RESULTS: Eighty-seven cases of transplantation were successful, with no serious complications, including radiation pneumonia. Compared with Group CT/TBI, Group TBI/CT showed similar incidence of complications (p=0.08), similar recent chemotherapy toxicity (p=0.833), and significantly lower recent radiation toxicity (p=0.000). CONCLUSIONS: TBI in the pretreatment of HSCT is safe and effective. Using TBI before the high-dose chemotherapy can maintain the same pretreatment effect, effectively reduce apparent immediate reaction/discomfort during TBI, reduce preparation workload of radiotherapy, and lower radiation side-effects. Further research is needed to expand its clinical application.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Ciclofosfamida/uso terapêutico , Transplante de Células-Tronco Hematopoéticas/métodos , Leucemia/terapia , Linfoma/terapia , Condicionamento Pré-Transplante/métodos , Irradiação Corporal Total/métodos , Adolescente , Adulto , Soro Antilinfocitário/administração & dosagem , Criança , Terapia Combinada , Ciclofosfamida/administração & dosagem , Citarabina/administração & dosagem , Feminino , Seguimentos , Humanos , Leucemia/tratamento farmacológico , Leucemia/cirurgia , Linfoma/tratamento farmacológico , Linfoma/cirurgia , Masculino , Pessoa de Meia-Idade , Dosagem Radioterapêutica , Estudos Retrospectivos , Irradiação Corporal Total/efeitos adversos , Adulto Jovem
7.
Med Oncol ; 27(3): 919-25, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19757213

RESUMO

Radiation-induced acute intestinal symptoms (RIAISs) are the most relevant complication of abdominal or pelvic radiation. Considering the negative impact of RIAIS on patients' daily activities, the preventive effects of berberine on RIAIS in patients were investigated. Thirty-six patients with seminoma or lymphomas were randomized to receive berberine oral (n = 18) or not (n = 18). Forty-two patients with cervical cancer were randomized to a trial group (n = 21) and control group (n = 21). Radiotherapy used a parallel opposed anterior and posterior. 300-mg berberine was administered orally three times daily in trial groups. Eight patients with RIAIS were treated with 300-mg berberine three times daily from the third to the fifth week. Toxicities, such as fatigue, anorexia/nausea, etc., were graded weekly according to CTC version 2.0. Patients with abdominal/pelvic radiation in the control group showed grade 1 fatigue, anorexia/nausea, colitis, vomiting, proctitis, weight loss, diarrhea and grade 2 anorexia/nausea, fatigue. Only grade 1 colitis, anorexia/nausea, and fatigue were seen in patients of abdominal radiation treated with berberine. Grade 1 fatigue, colitis, anorexia/nausea, and proctitis occurred in patients of pelvic radiotherapy treated with berberine. Pretreatment with berberine significantly decreased the incidence and severity of RIAIS in patients with abdominal/pelvic radiotherapy when compared with the patients of the control group (P < 0.05). RIAIS were reduced in patients with abdominal radiotherapy/pelvic radiation after receiving berberine treatment. Berberine significantly reduced the incidence and severity of RIAIS and postponed the occurrence of RIAIS in patients with abdominal or whole pelvic radiation.


Assuntos
Berberina/uso terapêutico , Enteropatias/prevenção & controle , Irradiação Linfática/efeitos adversos , Fitoterapia , Lesões por Radiação/prevenção & controle , Protetores contra Radiação/uso terapêutico , Radioterapia de Alta Energia/efeitos adversos , Abdome/efeitos da radiação , Doença Aguda , Síndrome Aguda da Radiação/etiologia , Síndrome Aguda da Radiação/prevenção & controle , Berberina/administração & dosagem , Carcinoma de Células Escamosas/radioterapia , Colite/etiologia , Colite/prevenção & controle , Feminino , Humanos , Enteropatias/etiologia , Linfoma/radioterapia , Masculino , Pessoa de Meia-Idade , Pelve/efeitos da radiação , Proctite/etiologia , Proctite/prevenção & controle , Protetores contra Radiação/administração & dosagem , Seminoma/radioterapia , Neoplasias Testiculares/radioterapia , Neoplasias do Colo do Útero/radioterapia
8.
Zhongguo Yi Liao Qi Xie Za Zhi ; 32(4): 296-8, 307, 2008 Jul.
Artigo em Chinês | MEDLINE | ID: mdl-18973043

RESUMO

OBJECTIVE: To explore the effect on the iso-center and OAR and PDD of the MV class X-ray coming from the linac when we use the glass mirror to replace an imported one. METHOD: Data collected by using a film and 3D water phantom OAR and PDD measuring methods based on the different conditions. Comparison and analysis of the effect levels for different thickness and material mirrors are made. RESULT: The PDD max error of the 4 mm general glass mirror is 6%.When the 8MV X-ray 720 Gy irradiation is given, the light field appears a dual cross lines and has darker brightness. The PDD max error of the 1.5 mm quartz glass mirror is less than 1%. When it accepts the equal radiation dose, the light field iso-center and OAR and field brightness are agreed well with clinical demands. CONCLUSION: Our practice shows that the 4 mm general glass mirror can't suffer the MV class X-ray irradiation but the thin quartz glass mirror can. So the thin quartz glass mirror can be used for the linac.


Assuntos
Aceleradores de Partículas/instrumentação , Doses de Radiação , Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...